Year |
Citation |
Score |
2016 |
Ortega RA, Barham W, Sharman K, Tikhomirov O, Giorgio TD, Yull FE. Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions. International Journal of Nanomedicine. 11: 2163-77. PMID 27274241 DOI: 10.2147/Ijn.S93483 |
0.67 |
|
2016 |
Ortega RA, Barham W, Sharman K, Tikhomirov O, Giorgio TD, Yull FE. Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions International Journal of Nanomedicine. 11: 2163-2177. DOI: 10.2147/IJN.S93483 |
0.651 |
|
2016 |
Barham W, Wilson A, Ortega R, Saskowski J, Tikhomirov O, Giorgio T, Khabele D, Yull FE. Abstract B70: Targeted activation of macrophages to limit ovarian cancer progression. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B70 |
0.606 |
|
2015 |
Ortega RA, Barham WJ, Kumar B, Tikhomirov O, McFadden ID, Yull FE, Giorgio TD. Biocompatible mannosylated endosomal-escape nanoparticles enhance selective delivery of short nucleotide sequences to tumor associated macrophages. Nanoscale. 7: 500-10. PMID 25408159 DOI: 10.1039/C4Nr03962A |
0.654 |
|
2015 |
Barham W, Tikhomirov O, Ortega R, Saskowski J, Thompson CS, Wilson A, Blackwell T, Mirafzali Z, Khabele D, Giorgio T, Yull FE. Abstract 294: A novel cancer therapeutic strategy: inducing cytotoxic functions in tumor-associated macrophages Immunology. 75: 294-294. DOI: 10.1158/1538-7445.Am2015-294 |
0.641 |
|
2014 |
Ortega R, Barham W, Tikhomirov O, Sharman K, Yull F, Giorgio T. Abstract 3630: Immunoengineering of tumor associated macrophages using targeted, siRNA delivering nanoparticles Cancer Research. 74: 3630-3630. DOI: 10.1158/1538-7445.Am2014-3630 |
0.679 |
|
2014 |
Barham W, Tikhomirov O, Chen L, Ortega R, Onishko H, Connelly L, Yull FE. Abstract 3010: The role of NF-kappaB in mammary tumor initiation Cancer Research. 74: 3010-3010. DOI: 10.1158/1538-7445.Am2014-3010 |
0.397 |
|
2013 |
Ortega RA, Barham W, Kumar B, Yu SS, Yull F, Giorgio TD. Abstract 3981: Reprogramming tumor associated macrophages toward an anti-tumor phenotype by targeting the NF-κB pathway using novel targeted nanotherapeutics. Cancer Research. 73: 3981-3981. DOI: 10.1158/1538-7445.Am2013-3981 |
0.714 |
|
2013 |
Barham W, Tikhomirov O, Chen L, Ortega R, Gleaves L, Onishko H, Sherrill T, Connelly L, Blackwell TS, Yull FE. Abstract 1545: Education of macrophages through modulation of NF-kappaB: an opportunity for targeted therapy. Cancer Research. 73: 1545-1545. DOI: 10.1158/1538-7445.Am2013-1545 |
0.472 |
|
2012 |
Ortega RA, Giorgio TD. A mathematical model of superparamagnetic iron oxide nanoparticle magnetic behavior to guide the design of novel nanomaterials Journal of Nanoparticle Research. 14. DOI: 10.1007/S11051-012-1282-X |
0.558 |
|
2011 |
Yu SS, Ortega RA, Reagan BW, McPherson JA, Sung HJ, Giorgio TD. Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 3: 620-46. PMID 21834059 DOI: 10.1002/Wnan.158 |
0.673 |
|
2011 |
Yu SS, Scherer RL, Ortega RA, Bell CS, O'Neil CP, Hubbell JA, Giorgio TD. Enzymatic- and temperature-sensitive controlled release of ultrasmall superparamagnetic iron oxides (USPIOs) Journal of Nanobiotechnology. 9. PMID 21352596 DOI: 10.1186/1477-3155-9-7 |
0.695 |
|
2011 |
Yu SS, Scherer RL, Ortega RA, Bell CS, O"Neil CP, Hubbell JA, Giorgio TD. Enzymatic- and temperature-sensitive controlled release of ultrasmall superparamagnetic iron oxides (USPIOs) (vol 9, pg 7, 2011) Journal of Nanobiotechnology. 9. DOI: 10.1186/1477-3155-9-51 |
0.66 |
|
Show low-probability matches. |